business. In February 2021, Charles River announced it would acquire Cognate BioServices, Inc. for $875 million. In March 2021, Charles River announced the...
18 KB (1,594 words) - 15:59, 12 September 2024
organization Cognate Bioservices for services supporting manufacture of its products for clinical trials. Their relationship with Cognate began before...
9 KB (1,104 words) - 15:39, 14 August 2024
Caladrius Biosciences Inc. (2019-08-07). "Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal...
28 KB (1,584 words) - 03:45, 11 August 2024